Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
3
×
national blog main
wisconsin blog main
wisconsin top stories
boston blog main
boulder/denver blog main
boulder/denver top stories
crispr
detroit blog main
detroit top stories
editas medicine
ipo
life sciences
nasdaq
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
abbvie
advaxis
aimmune therapeutics
akouos
alder biopharmaceuticals
alexander hardy
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew oxtoby
What
ceo
3
×
bio
roundup
acquisitions
announced
appoints
big
board
bosley's
bosley’s
bridge
bucks
cas
chair
collabs
company
covid
crime
crispr
daniel
deal
decades
departure
domestically
editas
exit
gilead
gilead’s
guiding
help
hendricks
introduce
ipo
katrine
medical
medicine
medicines
merrick
month
moves
Language
unset
Current search:
fda
×
ceo
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
NorthStar Names Merrick CEO, Appoints Hendricks as Board Chair